Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Cureus. 2024 Jun 4;16(6):e61635. doi: 10.7759/cureus.61635. eCollection 2024 Jun.
ABSTRACT
The type of liver cancer that occurs most frequently is hepatocellular carcinoma (HCC). The majority of cases of HCC are secondary to alcoholic cirrhosis or viral hepatitis. The presence of malignant cells with modest nuclear atypia that resemble normal hepatocytes and the lack of bare nuclei in the smears, which shows the neoplastic hepatocytes’ capacity, are characteristics of a well-differentiated HCC plasma membrane to tolerate smearing. We present the case of an 83-year-old male patient with a well-differentiated HCC, who had no etiological factors and no signs of alcohol cirrhotic liver, or any symptoms of liver disease which are the main causes of the HCC.
PMID:38966460 | PMC:PMC11223716 | DOI:10.7759/cureus.61635
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 2 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
A Case Presentation of Well-Differentiated Hepatocellular Carcinoma With No Sign of Liver Disease
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC) Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment The Role of Extrahepatic Features on the Development and Management of Hepatocellular Carcinoma in Steatotic Liver Disease The Role of Extrahepatic Features on the Development and Management of Hepatocellular Carcinoma in Steatotic Liver Disease Clinical outcomes of hepatocellular carcinoma surveillance in Melbourne, Australia Impact of multiple primary cancers on overall survival of patients with hepatocellular carcinoma Pivotal role of intestinal cholesterol and nuclear receptor LXR in metabolic liver steatohepatitis and hepatocarcinoma The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH SGLT2i impact on HCC incidence in patients with fatty liver disease and diabetes: a nation-wide cohort study in South Korea Radionuclide Therapy With 177Lu-PSMA in a Patient With Hepatocellular Carcinoma Integrated analysis of single-cell and bulk RNA sequencing data reveals a cellular senescence-related signature in hepatocellular carcinoma Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) Diet, lifestyle factors, comorbidities, and hepatocellular carcinoma risk in a middle eastern country: a case-control study Substitutions of saturated fat intakes with other macronutrients and foods and risk of NAFLD cirrhosis and all-cause hepatocellular carcinoma: a prospective cohort study Role of Culinary Indian Spices in the Regulation of TGF-β Signaling Pathway in Inflammation-Induced Liver Cancer Role of Culinary Indian Spices in the Regulation of TGF-β Signaling Pathway in Inflammation-Induced Liver Cancer TRIM45 facilitates NASH-progressed HCC by promoting fatty acid synthesis via catalyzing FABP5 ubiquitylation Proton-beam Therapy for Locally Advanced Hepatocellular Carcinoma With Inferior Vena Cava Tumor Thrombus: Case Report Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives The role and mechanism of SUMO modification in liver disease FGL1 and FGL2: emerging regulators of liver health and disease Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes Brusatol induces ferroptosis to inhibit hepatocellular carcinoma progression by targeting ATF3 Role of prostaglandin E2 and its receptors in chronic liver disease RNA modifications in the progression of liver diseases: from fatty liver to cancer RNA modifications in the progression of liver diseases: from fatty liver to cancer Overexpression of wild-type HRAS drives non-alcoholic steatohepatitis to hepatocellular carcinoma in mice CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma Outcomes and Recurrence Rate of Esophageal Varices after Endoscopic Treatment in Patients with Alcoholic Cirrhosis and Viral Cirrhosis Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis Non-cirrhotic Ascites: A Case of Severe Alcoholic Hepatitis Investigation of Markedly Elevated Liver Enzymes With Serendipitous Underlying Wilson's Disease With Chronic Alcohol Abuse A model of alcoholic liver disease based on different hepatotoxics leading to liver cancer Comparative outcomes of trans-arterial radioembolization in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease-induced HCC: a retrospective analysis Autoimmune hepatitis displays distinctively high multi-antennary sialylation on plasma N-glycans compared to other liver diseases Transarterial Embolization for Cystic Artery Pseudoaneurysm Caused by Hepatocellular Carcinoma Rupture in the Gallbladder: A Case Report The involvement of ROS-regulated programmed cell death in hepatocellular carcinoma Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma Alcohol use disorders and liver fibrosis: an update Immunotherapy and drug sensitivity predictive roles of a novel prognostic model in hepatocellular carcinoma Nanoquercetin and Extracellular Vesicles as Potential Anticancer Therapeutics in Hepatocellular Carcinoma MRI radiomics based on deep learning automated segmentation to predict early recurrence of hepatocellular carcinoma Fatal Cat Scratch Disease in Alcoholic Patient With Liver Cirrhosis: A Case Report Identification of differentially expressed mRNA/lncRNA modules in acutely regorafenib-treated sorafenib-resistant Huh7 hepatocellular carcinoma cells From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences Predicting Survival Using Whole-Liver MRI Radiomics in Patients with Hepatocellular Carcinoma After TACE Refractoriness Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy Development of an individualized model for predicting postoperative delirium in elderly patients with hepatocellular carcinoma Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations An Unusual Case of Alcoholic Liver Disease Associated with Secondary IgA Vasculitic Nephritis presenting as Rapidly Progressive Glomerulonephritis An Unusual Case of Alcoholic Liver Disease Associated with Secondary IgA Vasculitic Nephritis presenting as Rapidly Progressive Glomerulonephritis Clinical review and literature analysis of hepatic epithelioid angiomyolipoma in alcoholic cirrhosis: A case report Disseminated Tuberculosis Masquerading as Alcoholic Liver Disease The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition Postoperative Lenvatinib plus PD-1 blockade reduces early tumor recurrence in hepatocellular carcinoma with MVI (BCLC 0-A): A Propensity Score Matching Analysis An Insight Into Various Manifestations of Leptospirosis: A Unique Case Series From a State in Eastern India Spatial genomics: mapping human steatotic liver disease Safety and Effectiveness of Liv.52 DS in Patients With Varied Hepatic Disorders: An Open-Label, Multi-centre, Phase IV Study Cytological Perspective in a Case of Doege-Potter Syndrome With Hypoinsulinemic Hypoglycemia
Evidence Blueprint
A Case Presentation of Well-Differentiated Hepatocellular Carcinoma With No Sign of Liver Disease
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
A Case Presentation of Well-Differentiated Hepatocellular Carcinoma With No Sign of Liver Disease
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC) Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma An overview of mouse models of hepatocellular carcinoma A Review of Incidence and Related Risk Factors in the Development of Hepatocellular Carcinoma Gamma Delta T Cells: Role in Immunotherapy of Hepatocellular Carcinoma Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas Chest wall mass as a sign of ignored hepatocellular carcinoma in an alcoholic cirrhotic patient: a case report New Opportunities in the Systemic Treatment of Hepatocellular Carcinoma-Today and Tomorrow The effect of liver disease on hepatic microenvironment and implications for immune therapy The Role of Extrahepatic Features on the Development and Management of Hepatocellular Carcinoma in Steatotic Liver Disease The Role of Extrahepatic Features on the Development and Management of Hepatocellular Carcinoma in Steatotic Liver Disease Roles of peroxisome proliferator-activated receptors in hepatocellular carcinoma Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters? The Demographic and Clinicopathological Characteristics of Hepatopancreatobiliary Cancers From a Specialized Center in India Comparison of clinicopathologic characteristics among patients with HBV-positive, HCV-positive and Non-B Non-C hepatocellular carcinoma after hepatectomy: a systematic review and meta-analysis Recent advances in the management of hepatocellular carcinoma Integrated single-cell transcriptomics reveals the hypoxia-induced inflammation-cancer transformation in NASH-derived hepatocellular carcinoma Clinical outcomes of hepatocellular carcinoma surveillance in Melbourne, Australia Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease Identification of differentially methylated regions associated with both liver fibrosis and hepatocellular carcinoma Impact of multiple primary cancers on overall survival of patients with hepatocellular carcinoma Pivotal role of intestinal cholesterol and nuclear receptor LXR in metabolic liver steatohepatitis and hepatocarcinoma Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: the Multi-center Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study Multifunctional roles of inflammation and its causative factors in primary liver cancer: A literature review The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH A risk prediction model for hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis: HCC prediction for non-cirrhotic NAFLD SGLT2i impact on HCC incidence in patients with fatty liver disease and diabetes: a nation-wide cohort study in South Korea Regulation of Hepatocellular Carcinoma Epithelial-Mesenchymal Transition Mechanism and Targeted Therapeutic Approaches Insulin Use and The Risk of Hepatocellular Carcinoma: Insights and Implications Pituitary metastasis arising from hepatocellular carcinoma: a case report and update of the literature Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is associated with immune checkpoint upregulation Diagnosis and Treatment of Liver Disease: Current Trends and Future Directions Loss of cis-PTase function in the liver promotes a highly penetrant form of fatty liver disease that rapidly transitions to hepatocellular carcinoma Alternative splicing: a bridge connecting NAFLD and HCC Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma Radionuclide Therapy With 177Lu-PSMA in a Patient With Hepatocellular Carcinoma Integrated analysis of single-cell and bulk RNA sequencing data reveals a cellular senescence-related signature in hepatocellular carcinoma Analysis of genetic factors associated with fatty liver disease-related hepatocellular carcinoma Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players NCOA5 haploinsufficiency in myeloid-lineage cells sufficiently causes non-alcoholic steatohepatitis and hepatocellular carcinoma EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region Diet, lifestyle factors, comorbidities, and hepatocellular carcinoma risk in a middle eastern country: a case-control study Substitutions of saturated fat intakes with other macronutrients and foods and risk of NAFLD cirrhosis and all-cause hepatocellular carcinoma: a prospective cohort study Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome Small-interfering RNA targeting proprotein convertase subtilisin/kexin type 9 might promote fatty liver disease and hepatocellular carcinoma through upregulation of CD36 Past, present, and future of chemically induced hepatocarcinogenesis rodent models: Perspectives concerning classic and new cancer hallmarks The rs72613567:TA polymorphism in HSD17B13 is associated with survival benefit after development of hepatocellular carcinoma Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease Public knowledge and attitudes toward liver diseases and liver cancer in the Brazilian population: a cross sectional study Clinical Practice Guidelines For the Management of Hepatocellular Carcinoma: A Systematic Review Role of Culinary Indian Spices in the Regulation of TGF-β Signaling Pathway in Inflammation-Induced Liver Cancer Role of Culinary Indian Spices in the Regulation of TGF-β Signaling Pathway in Inflammation-Induced Liver Cancer